EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies

Jiayi Zhang iD, Shuyan Chen iD, Jialing Zhou iD, Bingqiong Wang iD, Xiaoning Wu iD, Xiaoqian Xu iD, Xinyu Zhao iD, Yuanyuan Kong iD, Xiaojuan Ou iD, Yameng Sun iD, Hong You iD

Gut and Liver · 2025

DOI: 10.5009/gnl250008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Gut and Liver, 2025. Verfasst von Jiayi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liver Research Center, Beijing Friendship Hospital, Capital Medical University, State Key Lab of Digestive Health, National Clinical Research Center …. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis B, Chronic, Liver, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepatitis B, ChronicLiverLiver CirrhosisAdultFemaleHumansMaleMiddle AgedAlanine TransaminaseBiomarkersBiopsyCohort StudiesElasticity Imaging Techniquesgamma-GlutamyltransferasePredictive Value of TestsROC Curve

Stichwörter der Autor:innen

Chronic hepatitis BDynamicsLiver cirrhosis/regressionNoninvasive diagnosisTransient elastography

Substanzen

Alanine TransaminaseAntiviral AgentsBiomarkersgamma-Glutamyltransferase

Autor:innen und Institutionen

  • Liver Research Center, Beijing Friendship Hospital, Capital Medical University, State Key Lab of Digestive Health, National Clinical Research Center of Digestive Diseases, Beijing Key Laboratory of Translational Medicin…
  • Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China.

ORCID-Profile: Jiayi Zhang, Shuyan Chen, Jialing Zhou, Bingqiong Wang, Xiaoning Wu, Xiaoqian Xu, Xinyu Zhao, Yuanyuan Kong, Xiaojuan Ou, Yameng Sun, Hong You

Förderung

  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, J., Chen, S., Zhou, J., Wang, B., Wu, X., Xu, X., Zhao, X., Kong, Y., Ou, X., Sun, Y., & You, H. (2025). Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies. Gut and Liver. https://doi.org/10.5009/gnl250008

Vancouver

Zhang J, Chen S, Zhou J, Wang B, Wu X, Xu X, et al. Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies. Gut and Liver. 2025. doi:10.5009/gnl250008

BibTeX
@article{Zhang2025,
  author = {Zhang, Jiayi and Chen, Shuyan and Zhou, Jialing and Wang, Bingqiong and Wu, Xiaoning and Xu, Xiaoqian and Zhao, Xinyu and Kong, Yuanyuan and Ou, Xiaojuan and Sun, Yameng and You, Hong},
  title = {Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies},
  journal = {Gut and Liver},
  year = {2025},
  doi = {10.5009/gnl250008}
}
Kostenlos starten →